Impact of Extended and Restricted Antibiotic Deescalation on Mortality.

Hwei Lin Teh Abdullah SarimahAnis Kausar GhazaliRahela Ambaras KhanAnitha RamadasChee Loon Leong

Published in: Antibiotics (Basel, Switzerland) (2021)

The results of this study reinforce that restricted or extended antibiotic de-escalation in patients does not significantly affect 30-day all-cause mortality compared to continuation with extended and restricted antibiotics.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
randomized controlled trial
type diabetes
cardiovascular events
risk factors
cardiovascular disease
clinical trial
coronary artery disease